In this podcast episode, Dr. Mansour interviews Cardiothoracic surgeon Dr. Joseph Zwischenberger “Zwisch,” who is a key member of the team at Verthermia. Dr. Zwisch and Dr. Mansour discuss the novel and FDA-approved innovative technique called HEATT® (Hyperthermic Extracorporeal Applied Tumor Therapy) — used for end-stage/terminal cancer.

Join Dr. Zwisch and Dr. Mansour as they further discuss the clinical parameters, applications, indications, and contraindications of this pioneering technique, harnessing the power of heat as a hormesis stressor to modulate immune function in the setting of cancer. Similar to EBOO (extracorporeal blood ozonation and oxygenation), HEATT® is an exciting and promising modality that may also have future applications for modulating dysregulated immune function in light of viral infections as well as complex chronic infectious diseases like Lyme, Bartonella, Babesia and more within the MSIDs picture (Multiple Systemic Infectious Disease Syndrome).